[Programmed stimulation in patients with malignant ventricular arrhythmias. I: Diagnostic value]

Area of Science:

• Cardiology
• Electrophysiology

Context:

• Sudden cardiac death (SCD) is a major cause of mortality in developed nations.
• Malignant ventricular arrhythmias, such as ventricular fibrillation and sustained ventricular tachycardia, are primary drivers of SCD, frequently linked to underlying coronary heart disease.

Purpose:

• To investigate the role of programmed electrical stimulation in managing patients with malignant ventricular arrhythmias.
• To assess the diagnostic and therapeutic utility of electrophysiological studies in identifying and treating arrhythmia triggers and myocardial vulnerability.

Summary:

• Sudden cardiac death is predominantly linked to malignant ventricular arrhythmias, triggered by complex ventricular extrasystoles and increased myocardial vulnerability.
• While noninvasive methods detect triggers, assessing myocardial vulnerability often requires invasive electrophysiological testing.
• Programmed electrical stimulation is crucial for reproducible arrhythmia initiation (85% for VT, 50% for VF) and, most importantly, for optimizing antiarrhythmic drug therapy in high-risk individuals.

Impact:

• Electrophysiological studies, particularly programmed stimulation, are vital for tailoring antiarrhythmic treatments.
• This approach aids in reducing the risk of sudden cardiac death in patients with documented malignant ventricular arrhythmias.
• Optimized antiarrhythmic therapy based on electrophysiological findings can significantly improve patient outcomes and reduce mortality.